Advanced search
Publication Cover
Journal of Pain & Palliative Care Pharmacotherapy Volume 37, 2023 - Issue 1
Submit an article Journal homepage
205
Views
0
CrossRef citations to date
0
Altmetric
Articles

Differences in Fentanyl Requirements in Terminally Ill Cancer Patients

Aya WatanabeAya Watanabe, MSc, Naoki Shimada, PhD and Noriko Fujiwara, MSc, Department of Palliative Medicine, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hiroto Ishiki, MD, Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan. Masanori Nojima, PhD, Center for Translational Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Arinobu Tojo, PhD, Department of Palliative Medicine, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.Correspondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3123-489X
ORCID Icon,
Naoki ShimadaAya Watanabe, MSc, Naoki Shimada, PhD and Noriko Fujiwara, MSc, Department of Palliative Medicine, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hiroto Ishiki, MD, Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan. Masanori Nojima, PhD, Center for Translational Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Arinobu Tojo, PhD, Department of Palliative Medicine, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID Iconhttps://orcid.org/0000-0003-0722-0076
ORCID Icon,
Hiroto IshikiAya Watanabe, MSc, Naoki Shimada, PhD and Noriko Fujiwara, MSc, Department of Palliative Medicine, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hiroto Ishiki, MD, Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan. Masanori Nojima, PhD, Center for Translational Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Arinobu Tojo, PhD, Department of Palliative Medicine, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID Iconhttps://orcid.org/0000-0002-0800-2161
ORCID Icon,
Noriko FujiwaraAya Watanabe, MSc, Naoki Shimada, PhD and Noriko Fujiwara, MSc, Department of Palliative Medicine, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hiroto Ishiki, MD, Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan. Masanori Nojima, PhD, Center for Translational Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Arinobu Tojo, PhD, Department of Palliative Medicine, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID Iconhttps://orcid.org/0000-0001-8201-9490
ORCID Icon,
Masanori NojimaAya Watanabe, MSc, Naoki Shimada, PhD and Noriko Fujiwara, MSc, Department of Palliative Medicine, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hiroto Ishiki, MD, Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan. Masanori Nojima, PhD, Center for Translational Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Arinobu Tojo, PhD, Department of Palliative Medicine, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID Iconhttps://orcid.org/0000-0002-8788-2522
ORCID Icon &
Arinobu TojoAya Watanabe, MSc, Naoki Shimada, PhD and Noriko Fujiwara, MSc, Department of Palliative Medicine, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hiroto Ishiki, MD, Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan. Masanori Nojima, PhD, Center for Translational Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Arinobu Tojo, PhD, Department of Palliative Medicine, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID Iconhttps://orcid.org/0000-0001-9016-1948
ORCID Icon
Pages 26-33 | Received 05 Apr 2021, Accepted 09 Nov 2022, Published online: 13 Dec 2022

References

  • van den Beuken-Van Everdingen MHJ, Hochstenbach LMJ, Joosten EAJ, Tjan-Heijnen VCG, Janssen DJA. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070–90.e9. doi:10.1016/j.jpainsymman.2015.12.340
  • Koo MM, Swann R, McPhail S, Abel GA, Elliss-Brookes L, Rubin GP, Lyratzopoulos G. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study. Lancet Oncol. 2020;21(1):73–9. doi:10.1016/S1470-2045(19)30595-9
  • WHO. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: World Health Organization; 2018.
  • Maltoni M, Scarpi E, Modonesi C, Passardi A, Calpona S, Turriziani A, Speranza R, Tassinari D, Magnani P, Saccani D, et al. A validation study of the WHO ­analgesic ladder: a two-step vs three-step strategy. Support Care Cancer. 2005;13(11):888–94. doi:10.1007/s00520-005-0807-6
  • Marinangeli F, Ciccozzi A, Leonardis M, Aloisio L, Mazzei A, Paladini A, Porzio G, Marchetti P, Varrassi G. Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage. 2004;27(5):409–16. doi:10.1016/j.jpainsymman.2003.10.006
  • Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, Chwistek M, Cleeland C, Craig D, Gafford E, et al. Adult cancer pain, version 3.2019. J Natl Compr Canc Netw. 2019;17(8):977–1007. doi:10.6004/jnccn.2019.0038
  • Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage. 1997;13(5):254–61. doi:10.1016/S0885-3924(97)00082-1
  • Clark AJ, Ahmedzai SH, Allan LG, Camacho F, Horbay GLA, Richarz U, Simpson K. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain. Curr Med Res Opin. 2004;20(9):1419–28. doi:10.1185/030079904X2114
  • Hadley G, Derry S, Moore RA, Wiffen PJ, Cochrane Pain, Palliative and Supportive Care Group. Transdermal fentanyl for cancer pain. Cochrane Database Syst Rev. 2013;2018(11):1–37. doi:10.1002/14651858.CD010270.pub2
  • Koike K, Terui T, Nagasako T, Horiuchi I, Machino T, Kusakabe T, Hirayama Y, Mihara H, Yamakage M, Kato J, et al. A new once-a-day fentanyl citrate patch (Fentos® Tape) could be a new treatment option in patients with end-of-dose failure using a 72-h transdermal fentanyl matrix patch. Support Care Cancer. 2016;24(3):1053–9. doi:10.1007/s00520-015-2880-9
  • Hall S, Gallagher RM, Gracely E, Knowlton C, Weschules D. The terminal cancer patient: effects of age, gender, and primary tumor site on opioid dose. Pain Med. 2003;4:125–34.
  • Mercadante S, Dardanoni G, Salvaggio L, Armata MG, Agnello A. Monitoring of opioid therapy in advanced cancer pain patients. J Pain Symptom Manage. 1997;13(4):204–12. doi:10.1016/S0885-3924(96)00302-8
  • Rees WD. Clinical oncology opioid needs of terminal care patients: variations with age and primary site. Clin Oncol. 1990;2(2):79–83. doi:10.1016/S0936-6555(05)80792-7
  • Ishida T, Naito T, Sato H, Kawakami J. Relationship between the plasma fentanyl and serum 4β-hydroxycholesterol based on CYP3A5 genotype and gender in patients with cancer pain. Drug Metab Pharmacokinet. 2016;31(3):242–8. doi:10.1016/j.dmpk.2016.04.001
  • Rasakham K, Liu-Chen LY. Sex differences in kappa opioid pharmacology. Life Sci. 2011;88(1-2):2–16. doi:10.1016/j.lfs.2010.10.007
  • Macintyre PE, Jarvis DA. Age is the best predictor of postoperative morphine requirements. Pain. 1996;64(2):357–64. doi:10.1016/0304-3959(95)00128-X
  • Ward SE, Goldberg N, Miller-McCauley V, Mueller C, Nolan A, Pawlik-Plank D, Robbins A, Stormoen D, Weissman DE. Patient-related barriers to management of cancer pain. Pain. 1993;52(3):319–24. doi:10.1016/0304-3959(93)90165-L
  • Hameed M, Hameed H, Erdek M. Pain management in pancreatic cancer. Cancers (Basel). 2010;3(1):43–60. doi:10.3390/cancers3010043
  • Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, Keefe FJ, Mogil JS, Ringkamp M, Sluka KA, et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976–82. doi:10.1097/j.pain.0000000000001939
  • Higginson IJ, McCarthy M. Validity of the support team assessment schedule: do staffs’ ratings reflect those made by patients or their families? Palliat Med. 1993;7(3):219–28. doi:10.1177/026921639300700309

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.